Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Apr;77(4):2219–2223. doi: 10.1073/pnas.77.4.2219

Macromolecular beta-adrenergic antagonists discriminating between receptor and antibody.

J Pitha, J Zjawiony, R J Lefkowitz, M G Caron
PMCID: PMC348684  PMID: 6154947

Abstract

The beta-adrenergic antagonist, alprenolol, was attached in an irreversible manner to macromolecular dextran via side arms that differed in length. The ability of these macromolecules to bind to the beta-adrenergic receptor of frog erythrocytes and to catecholamine-binding antibodies raised against partially purified receptors was studied. Compared to the parent drug the potency of binding of macromolecular alprenolol to the receptor decreased about 1/10, 1/600, and 1/8000 when the length of the arm separating alprenolol from the dextran moiety was 13, 8, and 4 atoms, respectively. In contrast, the binding potencies of the parent drug and of all its macromolecular derivatives for the antibody were within the same order of magnitude. Thus, conversion of a drug to a macromolecular form may not only sustain its binding activity but may also lead in a higher selectivity. The macromolecular derivatives described here may be suitable probes for investigation of the location and of the molecular properties of the binding sites for beta-adrenergic drugs.

Full text

PDF
2219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas D., Yaffe D., Skutelsky E. Ultrastructural probing of beta-adrenoreceptors on cell surfaces. FEBS Lett. 1978 Nov 1;95(1):173–176. doi: 10.1016/0014-5793(78)80077-5. [DOI] [PubMed] [Google Scholar]
  2. Bar R. S., Harrison L. C., Muggeo M., Gorden P., Kahn C. R., Roth J. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med. 1979;24:23–52. [PubMed] [Google Scholar]
  3. Bartsch W., Dietmann K., Leinert H., Sponer G. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers. Arzneimittelforschung. 1977;27(5):1022–1026. [PubMed] [Google Scholar]
  4. Caron M. G., Lefkowitz R. J. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. J Biol Chem. 1976 Apr 25;251(8):2374–2384. [PubMed] [Google Scholar]
  5. Caron M. G., Srinivasan Y., Pitha J., Kociolek K., Lefkowitz R. J. Affinity chromatography of the beta-adrenergic receptor. J Biol Chem. 1979 Apr 25;254(8):2923–2927. [PubMed] [Google Scholar]
  6. Caron M. G., Srinivasan Y., Snyderman R., Lefkowitz R. J. Antibodies raised against purified beta-adrenergic receptors specifically bind beta-adrenergic ligands. Proc Natl Acad Sci U S A. 1979 May;76(5):2263–2267. doi: 10.1073/pnas.76.5.2263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chu B. C., Whiteley J. M. High molecular weight derivatives of methotrexate as chemotherapeutic agents. Mol Pharmacol. 1977 Jan;13(1):80–88. [PubMed] [Google Scholar]
  8. Cuatrecasas P. Affinity chromatography. Annu Rev Biochem. 1971;40:259–278. doi: 10.1146/annurev.bi.40.070171.001355. [DOI] [PubMed] [Google Scholar]
  9. Hammond J. J., Kirkendall W. M. Antihypertensive drugs for the aging. Geriatrics. 1979 Jun;34(6):27–36. [PubMed] [Google Scholar]
  10. Kågedal L., Akerström S. Binding of covalent proteins to polysaccharides by cyanogen bromide and organic cyanates. I. Preparation of soluble glycine-, insulin- and ampicillin-dextran. Acta Chem Scand. 1971;25(5):1855–1859. doi: 10.3891/acta.chem.scand.25-1855. [DOI] [PubMed] [Google Scholar]
  11. Lefkowitz R. J., Limbird L. E., Mukherjee C., Caron M. G. The beta-adrenergic receptor and adenylate cyclase. Biochim Biophys Acta. 1976 Apr 13;457(1):1–39. doi: 10.1016/0304-4157(76)90012-5. [DOI] [PubMed] [Google Scholar]
  12. Melmon K. L., Weinstein Y., Bourne H. R., Poon T., Shearer G., Castagnoli N., Jr The pharmacological effects of conjugates of pharmacologically active amines to complex or simple carriers: a new class of drug. Mol Pharmacol. 1976 Sep;12(5):701–710. [PubMed] [Google Scholar]
  13. Mukherjee C., Caron M. G., Mullikin D., Lefkowitz R. J. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol. 1976 Jan;12(1):16–31. [PubMed] [Google Scholar]
  14. Noronha-Blob L., Vengris V. E., Pitha P. M., Pitha J. Uptake and fate of water-soluble, nondegradable polymers with antiviral activity in cells and animals. J Med Chem. 1977 Mar;20(3):356–359. doi: 10.1021/jm00213a009. [DOI] [PubMed] [Google Scholar]
  15. Ohno K., Pettigrew K. D., Rapoport S. I. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol. 1978 Sep;235(3):H299–H307. doi: 10.1152/ajpheart.1978.235.3.H299. [DOI] [PubMed] [Google Scholar]
  16. Pitha J. Reagents specific for cell surface components. Eur J Biochem. 1978 Jan 2;82(1):285–292. doi: 10.1111/j.1432-1033.1978.tb12022.x. [DOI] [PubMed] [Google Scholar]
  17. Rzeszotarski W. J., Gibson R. E., Eckelman W. C., Reba R. C. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols. J Med Chem. 1979 Jun;22(6):735–737. doi: 10.1021/jm00192a022. [DOI] [PubMed] [Google Scholar]
  18. Streefkerk D. G., Manjula B. N., Glaudemans C. P. An interpretation of the apparent dual specificity of some murine myeloma immunoglobulins with inulinbinding activity. J Immunol. 1979 Feb;122(2):537–541. [PubMed] [Google Scholar]
  19. Vauquelin G., Geynet P., Hanoune J., Strosberg A. D. Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3710–3714. doi: 10.1073/pnas.74.9.3710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Verlander M. S., Venter J. C., Goodman M., Kaplan N. O., Saks B. Biological activity of catecholamines covalently linked to synthetic polymers: proof of immobilized drug theory. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1009–1013. doi: 10.1073/pnas.73.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES